Chromatine/Épigénétique
Les inhibiteurs de la chromatine/épigénétique sont des composés qui modulent la structure et la fonction de la chromatine ou interfèrent avec les modifications épigénétiques, telles que la méthylation de l'ADN et la modification des histones. Ces inhibiteurs sont des outils essentiels pour étudier la régulation de l'expression génique et le rôle de l'épigénétique dans des maladies telles que le cancer, les troubles neurologiques et les anomalies du développement. En ciblant les processus épigénétiques, ces inhibiteurs peuvent modifier les schémas d'expression génique et offrir de nouvelles perspectives thérapeutiques. Chez CymitQuimica, nous offrons une large sélection d'inhibiteurs de la chromatine/épigénétique de haute qualité pour soutenir vos recherches en biologie moléculaire, génétique et épigénétique.
Sous-catégories appartenant à la catégorie "Chromatine/Épigénétique"
2235 produits trouvés pour "Chromatine/Épigénétique"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
JAK3-IN-9
CAS :<p>JAK3-IN-9, potent JAK3 inhibitor, IC50 of 1.7 nM, highly selective, low toxicity, orally bioavailable, shows anti-arthritis activity.</p>Formule :C17H23N5O4SCouleur et forme :SolidMasse moléculaire :393.46PARP-2/1-IN-2
CAS :<p>PARP-2/1-IN-2, Veliparib's enantiomer, inhibits PARP-1/2 (Ki: 5/2 nM) with 3 nM EC50 in cell assay.</p>Formule :C13H16N4OCouleur et forme :SolidMasse moléculaire :244.29ZLD10A
CAS :<p>ZLD10A is a highly potent and selective small molecule inhibitor of EZH2.</p>Formule :C37H48N4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :612.8WAY-260022
CAS :<p>WAY-260022 is the norepinephrine transporter inhibitor.</p>Formule :C21H31F3N2O2Degré de pureté :97.61% - 99.41%Couleur et forme :SolidMasse moléculaire :400.48LB-205
CAS :<p>LB-205 is a Zn 2+ dependent pan-inhibitor of class I and class II HDACs. It also has a long half-life in vivo.</p>Formule :C18H21N3O2SCouleur et forme :SolidMasse moléculaire :343.44CBP/p300-IN-10
CAS :<p>CBP/p300-IN-10, potent EP300/CREBBP inhibitor; IC50: 26 nM/39 nM. Potential for cancer research.</p>Formule :C25H24F5N5O3Couleur et forme :SolidMasse moléculaire :537.48INCB16562
CAS :<p>INCB16562: oral JAK1/2 inhibitor, halts IL-6/STAT3 in myeloma cells, boosts drug efficacy, stunts myeloma in mice.</p>Formule :C19H11Cl2N5Couleur et forme :SolidMasse moléculaire :380.23Guadecitabine
CAS :<p>Guadecitabine is a second-generation DNA methyltransferases inhibitor. It is used for research on acute myeloid leukemia and myelodysplastic syndromes.</p>Formule :C18H24N9O10PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.41Aurora A/PKC-IN-1
CAS :<p>Aurora A/PKC-IN-1 inhibits AurA (IC50: 6.9 nM), PKCα (IC50: 16.9 nM), and hinders breast cancer cell growth and spread.</p>Formule :C16H14N6OSe2Couleur et forme :SolidMasse moléculaire :464.24PRMT5-IN-10
CAS :<p>PRMT5-IN-10 exhibits promising structure-dependent inhibitory effect on the protein methyltransferase PRMT5:MEP50 complex.</p>Formule :C13H17N5O4Couleur et forme :SolidMasse moléculaire :307.31DDO-2093 dihydrochloride
<p>DDO-2093 dihydrochloride: potent MLL1-WDR5 inhibitor, IC50=8.6 nM, Kd=11.6 nM, antitumor.</p>Formule :C29H39Cl3FN9O3Couleur et forme :SolidMasse moléculaire :687.04Depudecin
CAS :<p>Depudecin, a polyketide from Alternaria brassicicola, has an 11-carbon chain with two epoxides and six stereocenters, inhibits HDAC, and is anti-angiogenic.</p>Formule :C11H16O4Couleur et forme :SolidMasse moléculaire :212.24UNC0379 TFA
CAS :<p>UNC0379 TFA inhibits SETD8 (IC50: 7.3 μM), selective for 15+ methyltransferases.</p>Formule :C25H36F3N5O4Couleur et forme :SolidMasse moléculaire :527.589Bromodomain inhibitor-8
CAS :<p>Bromodomain inhibitor-8 is an inhibitor of BET bromodomain used to treat autoimmune and inflammatory diseases.</p>Formule :C26H25ClN2O3Couleur et forme :SolidMasse moléculaire :448.94F-amidine
CAS :<p>F-amidine is a bioavailable irreversible PAD4 inactivator.</p>Formule :C14H19FN4O2Couleur et forme :SolidMasse moléculaire :294.32JNJ-9350
CAS :<p>JNJ-9350: SMOX inhibitor (IC50 0.01 μM), PAO inhibitor (IC50 0.79 μM), for cancer research.</p>Formule :C25H22N6OCouleur et forme :SolidMasse moléculaire :422.48CPI-455 HCl
CAS :<p>CPI-455: specific KDM5A inhibitor, IC50=10±1nM, increases H3K4me3, reduces DTPs in cancer cells.</p>Formule :C16H15ClN4ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :314.77ZL0454
CAS :<p>ZL0454 is an effective and selective Bromodomain-containing protein 4 inhibitors (IC50: 49 and 32 nM for BD1 and BD2).</p>Formule :C18H22N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :374.46S2101
CAS :<p>S2101 is a specific LSD1 histone demethylase inhibitor with an IC50 of 0.99 μM and a Ki of 0.61 μM, suitable for research into cancer and viral infections.</p>Formule :C16H16ClF2NODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :311.75LEM-14-1189
CAS :<p>LEM-14-1189 inhibits NSD1/2/3 (IC50: 418/111/60 μM), targets nuclear receptors, and may treat cancer and blood diseases.</p>Formule :C35H34N6O5S2Degré de pureté :98.06%Couleur et forme :SolidMasse moléculaire :682.81BRD4-BD1-IN-2
CAS :<p>BRD4-BD1-IN-2: Potent, selective BRD4-BD1 inhibitor, IC50=2.51µM; 20x less active on BD2; for cardiovascular/cancer research.</p>Formule :C20H15Br3N4O2Degré de pureté :99.39%Couleur et forme :SolidMasse moléculaire :583.07PI3K/HDAC-IN-1
CAS :<p>PI3K/HDAC-IN-1 is a potent PI3K and HDAC dual inhibitor(IC50s of 8.1 nM and 1.4 nM, respectively).</p>Formule :C22H25FN4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :428.46MAT2A-IN-4
CAS :<p>MAT2A-IN-4 can be used for the cancer research that is an inhibitor of methionine adenosyltransferase 2A (MAT2A)[1].</p>Formule :C18H16ClN3OCouleur et forme :SolidMasse moléculaire :325.79SIRT5 inhibitor 2
CAS :<p>SIRT5 inhibitor 2 (compound 49) has inhibitory activity through SIRT5-dependent deacetylation and cancer and neurodegenerative diseases.</p>Formule :C18H12Cl2N2O3SDegré de pureté :99.38% - 99.87%Couleur et forme :SolidMasse moléculaire :407.27MC4343
<p>MC4343, a potent dual inhibitor targeting both EZH2 and histone deacetylase, presents promising potential for cancer research applications.</p>Formule :C36H41N5O4Couleur et forme :SolidMasse moléculaire :607.74Furamidine dihydrochloride
CAS :<p>Furamidine dihydrochloride is a cell-permeable, selective PRMT1 inhibitor that also binds AT-rich DNA. It blocks proliferation in leukemia cell lines.</p>Formule :C18H18Cl2N4ODegré de pureté :98.16%Couleur et forme :SolidMasse moléculaire :377.27KD 5170
CAS :<p>KD 5170, a pan inhibitor of histone deacetylases (HDACs), demonstrates widespread antitumor activity both in vitro and in vivo [1].</p>Formule :C20H25N3O5S2Couleur et forme :SolidMasse moléculaire :451.561,2,3,4,5,6-Hexabromocyclohexane
CAS :<p>Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.</p>Formule :C6H6Br6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.54Bromodomain inhibitor-9
CAS :<p>Bromodomain inhibitor-9 selectively targets BRD4-1 (Kd 12 nM), used in metabolic, inflammatory, fibrotic, and autoimmune disease studies.</p>Formule :C24H28N4O5SCouleur et forme :SolidMasse moléculaire :484.57SYK/JAK-IN-1
CAS :<p>SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2.</p>Formule :C24H26N8O3Couleur et forme :SolidMasse moléculaire :474.52Tankyrase-IN-2
CAS :<p>Tankyrase-IN-2 is a selective, potent and orally active inhibitor of tankyrase with IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively</p>Formule :C17H14F2N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :316.3NSC-311068
CAS :<p>NSC-311068: A selective TET1 inhibitor, reducing 5hmC and AML cell viability with high TET1.</p>Formule :C10H6N4O4SCouleur et forme :SolidMasse moléculaire :278.24GNE-272
CAS :<p>GNE-272 is a selective inhibitor of CBP/EP300 (IC50: 0.02, 0.03, and 13 μM for CBP, EP300, and BRD4, respectively) and a selective in vivo probe for CBP/EP300.</p>Formule :C22H25FN6O2Couleur et forme :SolidMasse moléculaire :424.47SD-1029
CAS :<p>SD-1029 is a JAK2 inhibitor and a novel Stat3 activation inhibitor that inhibits Stat3 phosphorylation and JAK-STAT signaling.</p>Formule :C25H32Br2Cl2N2O3Couleur et forme :SolidMasse moléculaire :639.256(5H)-Phenanthridinone
CAS :<p>6(5H)-Phenanthridinone suppresses PARP1/2, reduces RDM4 cell growth, downregulates pro-inflammatory genes, and alleviates EAE symptoms in rats.</p>Formule :C13H9NOCouleur et forme :SolidMasse moléculaire :195.22NCC-149
CAS :<p>NCC-149 is a HDAC8 inhibitor.</p>Formule :C16H14N4O2SCouleur et forme :SolidMasse moléculaire :326.37MS-1020
CAS :<p>MS-1020 inhibits JAK3/STAT3, blocks active JAK3, suppresses JAK3/STAT5 signaling, and targets STAT3 in certain cells.</p>Formule :C21H18N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :346.38AC-93253 iodide
CAS :<p>AC-93253 iodide is a selective inhibitor of SIRT2. It significantly enhances the acetylation of tubulin p53 and histone H4.</p>Formule :C23H25IN2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :488.43Jaspamycin
CAS :<p>Jaspamycin (7-CN-7-C-Ino) does not bind with purified human PKARIα.</p>Formule :C12H12N4O5Couleur et forme :SolidMasse moléculaire :292.25Ac-Lys-AMC
CAS :<p>Ac-Lys-AMC (Hexanamide) is a fluorescent substrate for histone deacetylase HDACs.</p>Formule :C18H23N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :345.39(R)-UT-155
CAS :<p>(R)-UT-155 is a selective androgen receptor degrader (SARD) ligand.</p>Formule :C20H15F4N3O2Couleur et forme :SolidMasse moléculaire :405.35ZYJ-34v
CAS :<p>ZYJ-34v is an oral histone deacetylase inhibitor (HDACi) with potent antitumor activities.</p>Formule :C27H35N3O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :497.58TUL01101
CAS :<p>TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.</p>Formule :C22H25F2N5O2Couleur et forme :SolidMasse moléculaire :429.46ARTD10/PARP10-IN-1
CAS :<p>ARTD10/PARP10-IN-1 is a PARP inhibitor that inhibits ARTD8/PARP14 and has anticancer and antitumour activity for the study of prostate cancer.</p>Formule :C12H12N2O4Degré de pureté :99.14%Couleur et forme :SolidMasse moléculaire :248.23BPTF-IN-1
CAS :<p>BPTF-IN-1 (AU1), a BPTF bromodomain inhibitor with 2.8 μM affinity, shows higher selectivity over BRD4 and possesses antimalarial properties.</p>Formule :C23H23FN6O3Couleur et forme :SolidMasse moléculaire :450.47CPI-4203
CAS :<p>CPI-4203 is a selective inhibitor of KDM5 demethylases.</p>Formule :C16H14N4OCouleur et forme :SolidMasse moléculaire :278.31LSD1-IN-13
CAS :<p>LSD1-IN-13, an oral LSD1 blocker (IC50: 24.43 nM), boosts CD86 (EC50: 470 nM), and triggers AML cell line differentiation.</p>Formule :C23H29N3O2SCouleur et forme :SolidMasse moléculaire :411.56BI-9321
CAS :<p>BI-9321: Selective NSD3-PWWP1 antagonist, Kd 166 nM. Inactive against NSD2-PWWP1/NSD3-PWWP2.</p>Formule :C22H21FN4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :360.43SHP2/HDAC-IN-1
CAS :<p>SHP2/HDAC-IN-1: dual SHP2/HDAC inhibitor, IC50: 20.4 nM/25.3 nM, boosts antitumor immunity, aids cancer immunotherapy research.</p>Formule :C34H35Cl2N7O3Couleur et forme :SolidMasse moléculaire :660.59Acefylline piperazine
CAS :<p>Acefylline piperazine, a less toxic theophylline derivative, treats asthma and bronchitis by bronchodilation, stimulating respiration and CNS.</p>Formule :C9H10N4O4·xC4H10N2Couleur et forme :SolidMasse moléculaire :562.54PKN1/2-IN-1
CAS :<p>PKN1/2-IN-1 is a potent and selective PKN2 inhibitor, membrane permeability and anticancer.Protein kinase N proteins (PKN) are effectors of Rho GTPases.</p>Formule :C14H15N3ODegré de pureté :99.72%Couleur et forme :SolidMasse moléculaire :241.29BiBET
CAS :<p>BiBET is a potent, selective, bivalent inhibitor of BET bromodomains.</p>Formule :C26H30N10O3Couleur et forme :SolidMasse moléculaire :530.58KDM2B-IN-3
CAS :<p>KDM2B-IN-3, from patent WO2016112284A1 as compound 183c, potently inhibits histone demethylase KDM2B, with cancer research potential.</p>Formule :C25H30N2O2Couleur et forme :SolidMasse moléculaire :390.52GS-626510
CAS :<p>GS-626510 is an orally bioavailable inhibitor of BET family bromodomains (Kd: 0.59-3.2 nM for BRD2/3/4; IC50: 83 nM and 78 nM for BD1 and BD2).</p>Formule :C25H22N4OCouleur et forme :SolidMasse moléculaire :394.47AMPK activator
CAS :<p>AMPK activator</p>Formule :C22H21FO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :368.41,2-Didecanoylglycerol
CAS :<p>1,2-Didecanoylglycerol has functions as bioregulator of protein kinase C in human platelets.</p>Formule :C23H44O5Couleur et forme :SolidMasse moléculaire :400.59LW479
CAS :<p>LW479 is a novel inhibitor of HDAC and is a promising candidate for the prevention of breast cancer.</p>Formule :C21H23BrN2O4SCouleur et forme :SolidMasse moléculaire :479.39NSD3-IN-1
CAS :<p>NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.</p>Formule :C13H13N5OSCouleur et forme :SolidMasse moléculaire :287.34HPB
CAS :<p>HPB is a selective HDAC6 deacetylase inhibitor</p>Formule :C18H20N2O4Couleur et forme :SolidMasse moléculaire :328.36KDM5A-IN-1
CAS :<p>KDM5A-IN-1 is a pan-histidine lysine demethylase 5 KDM5 inhibitor that inhibits KDM5A, KDM5B, and KDM5C.Can be used in the study of cancer.</p>Formule :C15H22N4O2Degré de pureté :>99.99%Couleur et forme :SolidMasse moléculaire :290.36Galegine hydrochloride
CAS :<p>Galegine hydrochloride, from G. officinalis, leads to weight loss, activates AMPK in various cells, and has antibacterial properties.</p>Formule :C6H14ClN3Couleur et forme :SolidMasse moléculaire :163.65DC_517
CAS :<p>DC_517 is an inhibitor of DNA methyltransferase 1 (DNMT1) ( IC50: 1.7 μM; Kd: 0.91 μM).</p>Formule :C33H35N3O2Couleur et forme :SolidMasse moléculaire :505.65HDAC-IN-43
CAS :<p>HDAC-IN-43: potent HDAC 1/3/6 inhibitor (IC50: 82 nM HDAC1, 45 nM HDAC3, 24 nM HDAC6); weak PI3K/mTOR (IC50: 3.6μM, 3.7μM); anti-proliferative.</p>Formule :C22H28N6O4Couleur et forme :SolidMasse moléculaire :440.5L 888607 Racemate
CAS :<p>L 888607 Racemate blocks DP1 and TP receptors with 132 nM and 17 nM affinity.</p>Formule :C19H15ClFNO2SCouleur et forme :SolidMasse moléculaire :375.84Tyk2-IN-7
CAS :<p>Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM).</p>Formule :C18H15D3N6O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :401.46TK4b
CAS :<p>TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).</p>Formule :C21H22N2O2Couleur et forme :SolidMasse moléculaire :334.41Pulrodemstat Methylbenzenesulfonate
CAS :<p>LSD1-IN-7 Methylbenzenesulfonate is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.</p>Formule :C31H31F2N5O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :623.67ZIKV-IN-3
CAS :<p>ZIKV-IN-3, an andrographolide derivative, inhibits ZIKV NS5 MTase (IC50: 18.34 μM) and replication. Used for Zika virus research.</p>Formule :C39H41NO4Couleur et forme :SolidMasse moléculaire :587.75YM-53601 free base
CAS :<p>YM-53601 free base is an inhibitor of squalene synthetase which suppresses lipogenic biosynthesis and lipid secretion in rodents.</p>Formule :C21H21FN2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :336.4EP009
CAS :<p>EP009, a novel, selective, and orally active inhibitor of JAK3, induces therapeutic response in T-cell malignancies.</p>Formule :C14H24O2Couleur et forme :SolidMasse moléculaire :224.34MDK8228
CAS :<p>MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. MDK8228 downregulates IL-6, IL-ß and IFN-ß in macrophages.</p>Formule :C31H41N5O3Couleur et forme :SolidMasse moléculaire :531.69NVS-BET-1
CAS :<p>NVS-BET-1 is a BET bromodomain inhibitor. NVS-BET-1 can regulate keratinocyte plasticity.</p>Formule :C22H21ClN4O2Couleur et forme :SolidMasse moléculaire :408.88SIRT2-IN-11
CAS :<p>SIRT2-IN-11 (AEM1), a SIRT2 inhibitor (IC50 18.5μM), induces apoptosis and affects p53, used in cancer research.</p>Formule :C21H22N2OCouleur et forme :SolidMasse moléculaire :318.41RM65
CAS :<p>RM65 is an arginine methyltransferase inhibitor.</p>Formule :C34H32N2O4S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :596.76HIF-1α-IN-3
CAS :<p>HIF-1α-IN-3, also known as Compound (S)-3f, is a hypoxia-selective inhibitor of HIF-1α. It exhibits potent antiestrogenic activity [1].</p>Formule :C19H17N5O2Couleur et forme :SolidMasse moléculaire :347.37CBB1003
CAS :<p>CBB1003 is a new inhibitor of histone demethylase LSD1 (IC50: 10.54 μM).</p>Formule :C25H31N9O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :521.57PF-739
CAS :<p>PF-739 is an AMPK agonist that has been shown to activate AMPK in hepatocytes and skeletal muscle.</p>Formule :C23H23ClN2O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :442.89HDAC-IN-29
CAS :<p>HDAC-IN-29 (compound 13b) is a potent pan- HDAC inhibitor with antitumor activity.</p>Formule :C20H23N3O4SCouleur et forme :SolidMasse moléculaire :401.48DC-BPi-03
CAS :<p>DC-BPi-03 is a potent BPTF-BRD inhibitor with an IC 50 of 698.3 nM and a K d of 2.81 μM .</p>Formule :C14H14N4O2SDegré de pureté :98.96%Couleur et forme :SolidMasse moléculaire :302.35Butyrolactone 3
CAS :<p>Butyrolactone 3 (MB-3) is a Gcn5 inhibitor with weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and can be used in cancer.</p>Formule :C9H12O4Degré de pureté :98.99% - 99.5%Couleur et forme :SolidMasse moléculaire :184.19EZH2-IN-13
CAS :<p>EZH2-IN-13 is a potent EZH2 inhibitor with potential anticancer activity.EZH2-IN-13 may be used to study diseases associated with EZH2 activity.</p>Formule :C34H45N5O3Degré de pureté :98.3%Couleur et forme :SolidMasse moléculaire :571.75Butyzamide
CAS :<p>Butyzamide: oral Mpl activator, non-peptide, antagonizes TPO receptors, boosts hMpl, Ba/F3 cells, and enhances platelets in mice.</p>Formule :C29H32Cl2N2O5SDegré de pureté :99.51% - 99.83%Couleur et forme :SoildMasse moléculaire :591.55TNG908
CAS :<p>TNG908, a brain-penetrant PRMT5 inhibitor, is 15x more selective for MTAP mutant vs WT lines, useful in cancer studies.</p>Formule :C21H23N5O2SDegré de pureté :98.08% - 98.24%Couleur et forme :SolidMasse moléculaire :409.51PU139
CAS :<p>PU139 is a novel inhibitor of histone acetyltransferase (HAT).</p>Formule :C12H7FN2OSDegré de pureté :99.96%Couleur et forme :SolidMasse moléculaire :246.26Crebinostat
CAS :<p>Crebinostat: potent HDAC inhibitor, boosts synapsin-1 in neurons, enhances memory and gene Egr1 expression in mice.</p>Formule :C20H23N3O3Degré de pureté :94.96%Couleur et forme :SolidMasse moléculaire :353.41DCPLA-ME
CAS :<p>DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative</p>Formule :C21H38O2Degré de pureté :99.80%Couleur et forme :SolidMasse moléculaire :322.53STS-E412
CAS :<p>STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.</p>Formule :C15H15ClN4O2Degré de pureté :99.01%Couleur et forme :SolidMasse moléculaire :318.76Raxofelast
CAS :<p>Raxofelast (IRFI-016), a vitamin-like, hydrophilic antioxidant, mitigates ischemia-reperfusion in testis and may treat diabetic issues and atherosclerosis.</p>Formule :C15H18O5Degré de pureté :99.74% - 99.97%Couleur et forme :SolidMasse moléculaire :278.3BAY-299
CAS :<p>BAY-299 inhibits BRPF2, TAF1, and TAF1L with IC50s of 67, 8, and 106 nM.</p>Formule :C25H23N3O4Degré de pureté :99.53%Couleur et forme :SolidMasse moléculaire :429.47LEM-14
CAS :<p>LEM-14 is a potent NSD2-specific inhibitor (IC50:132 μM).LEM-14 may be used in the study of multiple myeloma.</p>Formule :C25H26N4O4SDegré de pureté :98.3%Couleur et forme :SolidMasse moléculaire :478.56CMP-5
CAS :<p>CMP-5 is a PRMT5 inhibitor with antiviral activity, inhibits PRMT5 methyltransferase activity, and can be used in the study of SARS virus infection.</p>Formule :C21H21N3Degré de pureté :98.68%Couleur et forme :SolidMasse moléculaire :315.41TM2-115
CAS :<p>TM2-115 is a inhibitor of malaria parasite histone methyltransferases that results in rapid and irreversible parasite death [1].</p>Formule :C28H38N6O2Degré de pureté :97.67%Couleur et forme :SolidMasse moléculaire :490.64ZEN-3219
CAS :<p>ZEN-3219 is a BET inhibitor, which has inhibitory effect on BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2).</p>Formule :C19H18N2O3Degré de pureté :99.06%Couleur et forme :SolidMasse moléculaire :322.36TGP-377/421
CAS :<p>TGP-377/421 (Targapre-miR-377/421) is a potent miR-377 and miR-421 dual inhibitor that inhibits miR-377 and miR-421 by binding to their functional sites.</p>Formule :C20H16N6Degré de pureté :98.48%Couleur et forme :SolidMasse moléculaire :340.38DW14800
CAS :<p>DW14800 is an inhibitor of PRMT5 (IC50 = 17 nM), enhances the transcription of HNF4α, and reduces the level of H4R3me2s.</p>Formule :C31H36N4O3Degré de pureté :99.55% - 99.68%Couleur et forme :SolidMasse moléculaire :512.64Cedazuridine
CAS :<p>Cedazuridine ((4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine) is an oral inhibitor of cytidine deaminase with antineoplastic properties.</p>Formule :C9H14F2N2O5Degré de pureté :99.66%Couleur et forme :SolidMasse moléculaire :268.21CEP-9722
CAS :<p>CEP-9722 is a PARP-1 and PARP-2 inhibitor with anticancer activity and is used in the study of ovarian cancer.</p>Formule :C24H26N4O3Degré de pureté :98.38% - 98.56%Couleur et forme :SolidMasse moléculaire :418.49GRK6-IN-1
CAS :<p>GRK6-IN-1 (compound 18) is a potent GRK6 blocker, with an IC50 of 120 nM, showing promise for multiple myeloma research.</p>Formule :C22H23ClN6O2Degré de pureté :99.37%Couleur et forme :SolidMasse moléculaire :438.91Procainamide
CAS :<p>Procainamide: DNMT1 inhibitor, Class 1A antiarrhythmic, promising for cancer and arrhythmia research.</p>Formule :C13H21N3ODegré de pureté :99.92% - 99.92%Couleur et forme :SolidMasse moléculaire :235.33CPUY074020
CAS :<p>CPUY074020 is a potent and orally bioavailable inhibitor of histone methyltransferase G9a (IC50: 2.18 μM) with anti-proliferative activity.</p>Formule :C25H28N4O2Degré de pureté :98.64%Couleur et forme :SolidMasse moléculaire :416.52
